Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Roche: Data for Breast Cancer Drug Candidate Giredestrant Support Potential Differentiated Status - Morningstar Canada
Roche: Data for Breast Cancer Drug Candidate Giredestrant Support Potential Differentiated Status Morningstar Canada
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results - Stocktwits
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results Stocktwits
New experimental drug could transform care for cancer patients - The Independent
New experimental drug could transform care for cancer patients The Independent
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? - simplywall.st
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? simplywall.st
Roche oral drug shown to keep breast cancer at bay, boosting shares - Reuters
Roche oral drug shown to keep breast cancer at bay, boosting shares Reuters
Roche Just Unleashed a Drug That Could Disrupt the Entire MS Market - Yahoo Finance
Roche Just Unleashed a Drug That Could Disrupt the Entire MS Market Khac Phu Nguyen November 10, 2025 1 min read ROG.SW +1.38% This article first appeared on GuruFocus....
Roche's experimental MS drug hits main goal in one of two key trials - Reuters
Roche's experimental MS drug hits main goal in one of two key trials Reuters
Roche taps an AI specialist to craft new brain drugs - BioPharma Dive
Roche taps an AI specialist to craft new brain drugs BioPharma Dive
Roche in ongoing discussions with US government over drug pricing, CEO says - Pharmaceutical Technology
Roche in ongoing discussions with US government over drug pricing, CEO says Pharmaceutical Technology